Literature DB >> 22248614

Early additional endoscopic submucosal dissection in patients with positive lateral resection margins after initial endoscopic submucosal dissection for early gastric cancer.

Sun Youn Bae1, Tae Hoon Jang, Byung-Hoon Min, Jun Haeng Lee, Poong-Lyul Rhee, Jong Chul Rhee, Jae J Kim.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22248614     DOI： 10.1016/j.gie.2011.09.044

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  18 in total

1.  Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer.

Authors:  Takahiro Toyokawa; Masaichi Ohira; Hiroaki Tanaka; Hiroaki Minamino; Katsunobu Sakurai; Yasuaki Nagami; Naoshi Kubo; Atsushi Yamamoto; Koji Sano; Kazuya Muguruma; Kazunari Tominaga; Hiroko Nebiki; Yoshito Yamashita; Tetsuo Arakawa; Kosei Hirakawa
Journal:  Surg Endosc       Date:  2015-10-13       Impact factor: 4.584

2.  Ablation of residual gastric tumor by argon plasma coagulation after endoscopic resection.

Authors:  Sooyeon Oh; Sang Gyun Kim; Ji Min Choi; Eun Hyo Jin; Jee Hyun Kim; Jong Pil Im; Joo Sung Kim; Hyun Chae Jung
Journal:  Surg Endosc       Date:  2016-06-28       Impact factor: 4.584

3.  A Risk-Scoring Model for Predicting Lymph Node Metastasis in Early Gastric Cancer Patients: a Retrospective Study and External Validation.

Authors:  Lihu Gu; Manman Chen; Parikshit Asutosh Khadaroo; Xueqiang Ma; Liya Kong; Xinlong Li; Hepan Zhu; Xin Zhong; Junhai Pan; XianFa Wang
Journal:  J Gastrointest Surg       Date:  2018-05-29       Impact factor: 3.452

4.  Secondary endoscopic submucosal dissection for residual or recurrent tumors after gastric endoscopic submucosal dissection.

Authors:  Shu Hoteya; Toshiro Iizuka; Daisuke Kikuchi; Toshifumi Mitani; Akira Matsui; Osamu Ogawa; Tsukasa Furuhata; Satoshi Yamashta; Akihiro Yamada; Mitsuru Kaise; Naohisa Yahagi
Journal:  Gastric Cancer       Date:  2013-12-06       Impact factor: 7.370

5.  Outcomes of endoscopic submucosal dissection for differentiated-type early gastric cancer with histological heterogeneity.

Authors:  Byung-Hoon Min; Kyoung-Mee Kim; Cheol Keun Park; Jun Haeng Lee; Poong-Lyul Rhee; Jong Chul Rhee; Jae J Kim
Journal:  Gastric Cancer       Date:  2014-05-07       Impact factor: 7.370

6.  Risk factors for local recurrence in patients with positive lateral resection margins after endoscopic submucosal dissection for early gastric cancer.

Authors:  Tae Kyun Kim; Gwang Ha Kim; Do Youn Park; Bong Eun Lee; Tae Yong Jeon; Dae Hwan Kim; Hong Jae Jo; Geun Am Song
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

7.  Clinical outcomes of early gastric cancer with lymphovascular invasion or positive vertical resection margin after endoscopic submucosal dissection.

Authors:  Geum Youb Noh; Ha Ra Ku; Youn Joo Kim; Su Cheol Park; Jin Kim; Chul Ju Han; Yu Chul Kim; Ki Young Yang
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

8.  A scoring system for patients with a tumor-positive lateral resection margin after endoscopic resection of early gastric cancer.

Authors:  Jae Jin Hwang; Kwung Jun Park; Young Soo Park; Hye Seung Lee; Hyuk Yoon; Cheol Min Shin; Nayoung Kim; Dong Ho Lee
Journal:  Surg Endosc       Date:  2015-11-12       Impact factor: 4.584

9.  Risk factors of residual or recurrent tumor in patients with a tumor-positive resection margin after endoscopic resection of early gastric cancer.

Authors:  Hyuk Yoon; Sang Gyun Kim; Jeongmin Choi; Jong Pil Im; Joo Sung Kim; Woo Ho Kim; Hyun Chae Jung
Journal:  Surg Endosc       Date:  2012-12-18       Impact factor: 4.584

10.  Risk Factors Associated with Lymph Node Metastasis for Early Gastric Cancer Patients Who Underwent Non-curative Endoscopic Resection: a Systematic Review and Meta-analysis.

Authors:  Bochao Zhao; Jingting Zhang; Jiale Zhang; Rui Luo; Zhenning Wang; Huimian Xu; Baojun Huang
Journal:  J Gastrointest Surg       Date:  2018-09-04       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.